Study of Differences in the VEGFR2 Inhibitory Activities between Semaxanib and SU5205 Using 3D-QSAR, Docking, and Molecular Dynamics Simulations

Camila Muñoz, Francisco Adasme, Ariela Vergara-Jaque, Jans Alzate-Morales, Torsten Kniess, Julio Caballero
February 1, 2012
Learn More
LinkedIn